文献速递新生儿儿童感染

新生儿重症监护病房侵袭性真菌感染预防中氟康唑剂量的网络Meta分析

Fluconazole Doses Used for Prophylaxis of Invasive Fungal Infection in Neonatal Intensive Care Units: A Network Meta-Analysis.
PubMed 文献 · J Pediatr · 2017-03-10

结果显示3和6 mg/kg氟康唑在减少侵袭性念珠菌感染及感染相关死亡方面均优于安慰剂,但三种剂量间无统计学显著差异。结论推荐使用最低剂量3 mg/kg进行念珠菌预防,因提高剂量未增加疗效且可能增加毒性和成本。

要点

  • 3和6 mg/kg氟康唑预防侵袭性念珠菌感染及感染相关死亡均优于安慰剂。
  • 3、4、6 mg/kg三种氟康唑剂量间疗效无统计学显著差异。
  • 推荐使用最低剂量3 mg/kg进行新生儿念珠菌预防。

核心结论

  • 推荐使用最低氟康唑剂量3 mg/kg用于新生儿念珠菌预防,因提高剂量未增加疗效且潜在毒性及成本更高。

主要发现

  • 以侵袭性念珠菌感染发生率为结局,3和6 mg/kg氟康唑优于安慰剂(OR分别为5.48 [95%可信区间1.81-18.94]和2.63 [1.18-7.02])。
  • 以侵袭性念珠菌感染相关死亡为结局,3和6 mg/kg氟康唑优于安慰剂(OR分别为15.32 [1.54-54.31]和9.14 [1.26-142.7])。
  • 三种剂量(3、4、6 mg/kg)之间的数据无统计学显著差异。

关键数值与推荐

  • 纳入研究使用的氟康唑剂量为3、4或6 mg/kg。
  • 3 mg/kg氟康唑对比安慰剂:侵袭性念珠菌感染OR 5.48(95%可信区间1.81-18.94),感染相关死亡OR 15.32(1.54-54.31)。
  • 6 mg/kg氟康唑对比安慰剂:侵袭性念珠菌感染OR 2.63(95%可信区间1.18-7.02),感染相关死亡OR 9.14(1.26-142.7)。

临床怎么用

  • 在NICU新生儿中预防侵袭性念珠菌感染时,可优先选用3 mg/kg氟康唑,避免不必要的剂量增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the safety and efficacy of different doses of fluconazole used for invasive prophylaxis of fungal infection in neonates. STUDY DESIGN: A systematic search was conducted with PubMed, Scopus, and Web of Science. A manual search was performed as well. Only randomized controlled trials of neonates in a neonatal intensive care unit (NICU) who received fluconazole prophylaxis for invasive fungal infection, regardless of the dose or therapeutic regimen, were included in this review. Data on baseline characteristics, outcomes incidence of proven invasive Candida infection, overall mortality, and invasive Candida infection-related mortality were extracted. RESULTS: Eleven studies were included in the review, with fluconazole doses of 3, 4, or 6?mg/kg. When the incidence of invasive Candida and invasive Candida-related mortality were considered as outcomes, the 3 and 6?mg/kg fluconazole doses were found to be statistically superior to placebo (OR, 5.48 [95% credible interval, 1.81-18.94] and 2.63 [1.18-7.02], respectively, and 15.32 [1.54-54.31] and 9.14 [1.26-142.7], respectively), but data for the 3 doses were not statistically significantly different. CONCLUSIONS: Use of the lowest fluconazole dose (3?mg/kg) should be recommended for Candida prophylaxis in neonates, given that increasing the fluconazole dose is not associated with higher efficacy and has greater potential for toxicity and increased cost.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Leonart LP, Tonin FS, Ferreira VL, et al. Fluconazole Doses Used for Prophylaxis of Invasive Fungal Infection in Neonatal Intensive Care Units: A Network Meta-Analysis. J Pediatr. 2017. PMID: 28285752. doi:10.1016/j.jpeds.2017.02.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。